JNJ

226.85

+0.95%↑

ISRG

520.71

-0.8%↓

ABT

105.9

-1.36%↓

MDT

100.73

-0.46%↓

133.82

-1.41%↓

JNJ

226.85

+0.95%↑

ISRG

520.71

-0.8%↓

ABT

105.9

-1.36%↓

MDT

100.73

-0.46%↓

133.82

-1.41%↓

JNJ

226.85

+0.95%↑

ISRG

520.71

-0.8%↓

ABT

105.9

-1.36%↓

MDT

100.73

-0.46%↓

133.82

-1.41%↓

JNJ

226.85

+0.95%↑

ISRG

520.71

-0.8%↓

ABT

105.9

-1.36%↓

MDT

100.73

-0.46%↓

133.82

-1.41%↓

JNJ

226.85

+0.95%↑

ISRG

520.71

-0.8%↓

ABT

105.9

-1.36%↓

MDT

100.73

-0.46%↓

133.82

-1.41%↓

Home・Aandelen Lijst・Clover Health Investments Corp

Clover Health Investments Corp

Open

2.3 -2.54

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.29

Max

2.38

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -24M
Verkoop	19M 497M
Winstmarge	-4.908
Werknemers	570
EBITDA	-14M -24M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+56.78% upside

Dividenden
By Dow Jones
Volgende Winsten	26 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-600M 1.3B
Vorige openingsprijs	4.84
Vorige sluitingsprijs	2.3

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

3.4 / 3.77 Steun & Weerstand

Clover Health Investments Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 jan 2026, 23:07 UTC

Winsten

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 jan 2026, 21:27 UTC

Winsten

Texas Instruments 4Q Sales Rise, Profit Falls

27 jan 2026, 23:55 UTC

Marktinformatie

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 jan 2026, 23:39 UTC

Marktinformatie

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 jan 2026, 23:19 UTC

Winsten

SK Innovation Posts Net Loss for Second Consecutive Year

27 jan 2026, 23:19 UTC

Winsten

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 jan 2026, 23:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

27 jan 2026, 23:11 UTC

Marktinformatie

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 jan 2026, 23:07 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 jan 2026, 22:17 UTC

Marktinformatie

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 jan 2026, 22:06 UTC

Winsten

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 jan 2026, 21:51 UTC

Winsten

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

27 jan 2026, 21:43 UTC

Winsten

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 jan 2026, 21:41 UTC

Winsten

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 jan 2026, 21:38 UTC

Winsten

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 jan 2026, 21:32 UTC

Winsten

Ampol: Modest Profit From F&I International in 2025

27 jan 2026, 21:32 UTC

Winsten

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 jan 2026, 21:31 UTC

Winsten

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 jan 2026, 21:31 UTC

Winsten

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 jan 2026, 21:30 UTC

Winsten

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 jan 2026, 21:28 UTC

Winsten

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Peer Vergelijking

Prijswijziging

Clover Health Investments Corp Prognose

Koersdoel

By TipRanks

56.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3.7 USD 56.78%

Hoogste 3.7 USD

Laagste 3.7 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Clover Health Investments Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Clover Health Investments Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

3.4 / 3.77Steun & Weerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.